T1	Participants 77 117	immune function in persons with HIV/AIDS
T2	Participants 271 364	persons with human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS)
T3	Participants 499 540	11 clinically stable, HIV-infected adults
T4	Participants 1397 1418	persons with HIV/AIDS
